Letter to the editor
Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid

https://doi.org/10.1016/j.jaci.2013.01.018Get rights and content

First page preview

First page preview
Click to open first page preview

References (10)

  • P. Garzon et al.

    Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients

    Gen Pharmacol

    (1985)
  • M. Gottlicher et al.

    Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

    EMBO J

    (2001)
  • M. Kaiser et al.

    The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma

    Haematologica

    (2006)
  • A. Nencioni et al.

    Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity

    Clin Cancer Res

    (2007)
  • T. Yamaguchi et al.

    Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression

    Genes Dev

    (2010)
There are more references available in the full text version of this article.

Cited by (0)

Supported by the Federal Ministry of Education and Research (BMBF 01 EO 0803 to M.R.) and by the Deutsche Krebshilfe (project no. 108935 to H.E.).

Disclosure of potential conflict of interest: S. L. Nutt has been supported by one or more grants from the National Health and Medical Research Council of Australia. The rest of the authors declare that they have no relevant conflicts of interest.

These authors contributed equally to this work.

View full text